|Articles|October 12, 2020
Patient Support Programs: Considerations for Crisis Management and Risk Mitigation
Author(s)Covance
This whitepaper discusses the importance of patient support programs and why a robust risk mitigation plan is critical to ensure that patients receive their therapy during crises.
Related Content
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies Completes $150 Million Financing
4
What Pharma Investors Should Expect in the Current Regulatory Environment
5